Therapeutic options for patients with advanced gastric or gastro-oesophageal junction adenocarcinomas are rapidly evolving.1 Although chemotherapy alone results in a median survival of less than a ...
A prototype of a new oral cancer diagnosis device, developed by the University of Liverpool, has demonstrated promising results during preliminary tests on histopathology specimens.